Virax Biolabs Group Ltd - Ordinary Shares - Class A

NASDAQ:VRAX

0.61

-0.01 (-1.48%)

7:57:31 PM EDT: $0.60 -0.01 (-0.96%)

Market Cap (Intraday)	2.59M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.01 Million
Adjusted EPS	-$0.34

See more estimates

10-Day MA	$0.68
50-Day MA	$0.83
200-Day MA	$1.34

See more pivots

Virax Biolabs Group Ltd - Ordinary Shares - Class A Stock, NASDAQ:VRAX

Bo'Ness Road Newhouse, Lanarkshire, Scotland ML1 5UH

United Kingdom

Phone: +44.20.7788.7414

Number of Employees: 17

http://www.viraxbiolabs.com

Description

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.